--Novartis AG is considering selling assets including its respiratory and ophthalmology businesses as it seeks to invest in innovative medicines, Bloomberg reports, citing unnamed sources.

--The Swiss pharma major's ophthalmology business alone could be worth about $5 billion, according to Bloomberg.

--Any sales of the businesses are likely to start in 2023 but there is no certainty that the deliberations will result in disposals, Bloomberg reports.

Full story: https://bloom.bg/3txZE7V

Write to Cecilia Butini at cecilia.butini@wsj.com

(END) Dow Jones Newswires

November 16, 2022 10:02 ET (15:02 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Novartis
Novartis (NYSE:NVS)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Novartis